CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $122,000 | +14.0% | 4,652 | +52.1% | 0.00% | 0.0% |
| Q1 2022 | $107,000 | -8.5% | 3,059 | -15.9% | 0.00% | 0.0% |
| Q4 2021 | $117,000 | -7.9% | 3,639 | -15.7% | 0.00% | 0.0% |
| Q3 2021 | $127,000 | -43.3% | 4,319 | -50.6% | 0.00% | -25.0% |
| Q2 2021 | $224,000 | +10.9% | 8,744 | -40.8% | 0.00% | 0.0% |
| Q1 2021 | $202,000 | -43.7% | 14,762 | -32.0% | 0.00% | -50.0% |
| Q4 2020 | $359,000 | – | 21,701 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
| Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
| Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
| Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
| Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
| Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
| Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
| Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
| HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
| FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |